The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant-adjuvant pembrolizumab in clinical stage IIB/C melanoma.
 
John Miura
Consulting or Advisory Role - Skyline Diagnostics; Skyline Diagnostics
Research Funding - Merck (Inst)
 
Mohammad Farooq
No Relationships to Disclose
 
Phyllis Gimotty
Patents, Royalties, Other Intellectual Property - Coukos G, Buckanovich R, Gimotty PA: Tumor vasculature markers and methods of use thereof. European Patent Office EP1987160A2; Coukos G, Buckanovich R, Gimotty PA: Tumor vasculature markers and methods of use thereof. United States Patent Number 11/657,719, 2007.
 
Tara Mitchell
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst)
 
Ravi Amaravadi
Stock and Other Ownership Interests - Pinpoint Therapeutics
Consulting or Advisory Role - Tasca Therapeutics
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Deciphera (Inst); Merck KGaA (Inst); SpringWorks Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - I am inventor on 3 patents related to dimeric chloroquines. The patents are owned by UPenn and licensed to Pinpoint Therapeutics (Inst)
Travel, Accommodations, Expenses - Merck KGaA
 
Lynn Schuchter
Consulting or Advisory Role - Incyte
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Stand up to Cancer
 
Sheryl Mitnick
No Relationships to Disclose
 
Xiaowei Xu
Stock and Other Ownership Interests - CureBiotech; Exio Bioscience
Research Funding - Incyte
Patents, Royalties, Other Intellectual Property - Resiquimod topical and injectable compositions for the treatment of neoplastic skin conditions
 
Alexander Huang
Research Funding - Bristol-Myers Squibb; Merck
 
Michael Davies
Consulting or Advisory Role - ABM; Apexigen; Array BioPharma; Bristol-Myers Squibb; Eisai; Genentech/Roche; Iovance Biotherapeutics; NanoString Technologies; Novartis; Nurix; Pfizer; Replimune
Research Funding - ABM (Inst); AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lead Pharma (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Pfizer (Inst); Sanofi (Inst)
 
Rodabe Amaria
Consulting or Advisory Role - Erasca, Inc; IO Biotech; KSQ Therapeutics; Obsidian Therapeutics; Replimune
Research Funding - Bristol-Myers Squibb (Inst); Erasc (Inst); Genentech (Inst); iovance Biotherapeutics (Inst); KSQ Therapeutics (Inst); Novartis (Inst); Obsidian Therapeutics (Inst); OnKure (Inst); Regeneron (Inst)
 
Jason Chesney
Consulting or Advisory Role - Iovance Biotherapeutics; Iovance Biotherapeutics
Research Funding - Amgen; Bristol-Myers Squibb; Iovance Biotherapeutics; Replimune
Patents, Royalties, Other Intellectual Property - University of Louisville US Patents
 
Roi Weiser
No Relationships to Disclose
 
Jeffrey Gershenwald
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Novartis; Novartis; Regeneron; Syndax
Patents, Royalties, Other Intellectual Property - mercator therapeutics; UpToDate
 
Kelly McMasters
Research Funding - Merck; Merck
Patents, Royalties, Other Intellectual Property - patent and patent pending for translational research. No royalties, no licensing, no funding
Other Relationship - Annals of Surgical Oncology
(OPTIONAL) Uncompensated Relationships - UofL Health
 
Giorgos Karakousis
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
Research Funding - Merck (Inst)